Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q2 EPS of ($1.11), $0.24 worse than the analyst estimate of ($0.87).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36